Early Diagnosis and Biomarkers in Dementia

Early diagnosis of dementia is crucial for effective intervention and slowing disease progression. Advances in biomarkers—biological indicators of disease—are enhancing diagnostic accuracy and enabling earlier detection. Biomarkers for dementia include amyloid plaques and tau protein tangles in Alzheimer's disease, detectable through PET scans or cerebrospinal fluid analysis. Additionally, genetic markers, neuroimaging (MRI, fMRI), and blood-based tests are being researched for their potential to identify dementia at its earliest stages. Early detection allows for timely treatment, better management of symptoms, and improved outcomes for patients and caregivers.

    Related Conference of Early Diagnosis and Biomarkers in Dementia

    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Early Diagnosis and Biomarkers in Dementia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in